New Delhi, November 29

After a Chennai-based volunteer served a legal notice to the Serum Institute of India (SII) demanding Rs 5 crore compensation for the alleged neurological complications he developed after being administered a test dose of its Covishield vaccine, the SII has now countered the allegation with a demand of Rs 100 crore as damages to its reputation while terming his claims “malicious and misconceived in nature”.

The Pune-based pharma giant said “there is absolutely no correlation with the vaccine trial and the medical condition of the volunteer”. The SII said the medical team informed the volunteer that the complications were unrelated to the test dose administered to him. — IANS